ARCHITECT CA19-9XR
Report
- Report Number
- 3002809144-2025-00404
- Event Type
- Malfunction
- Date Received
- December 22, 2025
- Date of Event
- December 17, 2025
- Report Date
- January 21, 2026
- Manufacturer
- ABBOTT GMBH
- Product Code
- NIG
- UDI-DI
- 00380740137175
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
A COMPLAINT INVESTIGATION WAS CONDUCTED FOR THE ARCHITECT CA19-9XR REAGENT, LOT 77713FP00. REVIEW OF TRACKING AND TRENDING BY LIST NUMBER AND BY COMPLAINT LOT DID NOT IDENTIFY ANY TRENDS. DEVICE HISTORY REVIEW DID NOT IDENTIFY ANY NONCONFORMANCES, POTENTIAL NONCONFORMANCES, OR DEVIATIONS ASSOCIATED WITH THE COMPLAINT LOT. THE OVERALL PERFORMANCE OF THE ARCHITECT CA19-9XR REAGENTS IN THE FIELD WAS REVIEWED USING DATA GATHERED FROM CUSTOMERS WORLDWIDE. REVIEW SHOWS THE MEDIAN PATIENT RESULT FOR THE LOT IS WITHIN THE ESTABLISHED LIMITS, INDICATING THE LOT IS PERFORMING AS EXPECTED. LABELING WAS REVIEWED AND ADEQUATELY ADDRESSES THE ISSUE. BASED ON THE INVESTIGATION, THERE IS NO SYSTEMIC ISSUE OR DEFICIENCY OF THE ARCHITECT CA19-9XR REAGENT, LOT 77713FP00.
AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE. THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 2K91-39 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 2K91 - 39, WITH 510K/PMA/BLA NUMBER K052000.
THE CUSTOMER REPORTED FALSELY ELEVATED ARCHITECT CA 19-9XR AND PROVIDED THE FOLLOWING DATA: ORIGINAL RESULT WAS >1200 ON LOT 77713FP00. PER THE CUSTOMER DISCREPANT RESULTS WERE NOT REPORTED OUT TO THE MEDICAL PROVIDER. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.
THE CUSTOMER REPORTED FALSELY ELEVATED ARCHITECT CA 19-9XR AND PROVIDED THE FOLLOWING DATA: ORIGINAL RESULT WAS >1200 ON LOT 77713FP00. PER THE CUSTOMER DISCREPANT RESULTS WERE NOT REPORTED OUT TO THE MEDICAL PROVIDER. THERE WAS NO REPORTED IMPACT TO PATIENT MANAGEMENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2445326 | ARCHITECT CA19-9XR | SYSTEM, TEST, CARBOHYDRATE AG (CA19-9), FOR MONIT AND MGMT OF PANCREATIC CANCER | NIG | ABBOTT GMBH | 77713FP00 | 00380740137175 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | ARC I2K PROC MOD, 03M74-01, (B)(6) |